E-News - November 2022
Alliance Group Chair Nominating Committee
group chair - Alliance FOR CLINICAL TRIALS IN ONCOLOGY
The Alliance for Clinical Trials in Oncology (Alliance), a national clinical research group sponsored by the National Cancer Institute (NCI), is seeking nominations for the position of Group Chair.
The Alliance Group Chair will be responsible for all scientific, financial, and administrative activities of the Alliance and will chair the Alliance Board of Directors and Executive Committee. The Group Chair will serve as principal investigator of the Alliance NCI National Clinical Trials Network (NCTN) grant, NCI Community Oncology Research Program grant, other federal and non-federal grants, and contracts that support the Alliance infrastructure and programs. The Group Chair will oversee the activities of the Alliance programs and work with the Group Statistician and Alliance Program Principal Investigators. The Alliance programs include Statistics and Data Management, Central Protocol Operations, Translational Research, Cancer Control, and Procedure-Based Therapy. The Alliance Board of Directors shall elect the Alliance Group Chair for a six-year term.
The Nominating Committee will present a slate of candidates to the Alliance Board of Directors by April 2023. Thereafter, it is anticipated that an election for Group Chair will occur within 30 days. The Group Chair candidate will also be eligible to stand for election, as the President of the Alliance for Clinical Trials in Oncology Foundation.
Ideal candidates will have a strong track record in clinical and/or translational cancer research, experience in the design and conduct of cancer clinical trials, as well as significant leadership and administrative experience. Please submit a letter of nomination with a summary of the nominee's qualifications and curriculum vitae, along with any questions, by Friday, January 6, 2023, to Jeffrey Kirshner, MD, Chair of the Alliance Group Chair Nominating Committee at GroupChairSearch@AllianceNCTN.org.
